CA9 and breast carcinoma: Although CA IX is not currently used as a critical diagnostic marker in the clinical management of breast cancer, studies have confirmed that CA IX expression is associated with worse recurrence-free survival and overall survival in invasive breast cancer, suggesting important potential clinical significance and highlighting the need for further evaluation of its prognostic value in breast cancer [110].